全文获取类型
收费全文 | 1277146篇 |
免费 | 100019篇 |
国内免费 | 1988篇 |
专业分类
耳鼻咽喉 | 18445篇 |
儿科学 | 44406篇 |
妇产科学 | 35052篇 |
基础医学 | 182261篇 |
口腔科学 | 33636篇 |
临床医学 | 111332篇 |
内科学 | 258192篇 |
皮肤病学 | 28048篇 |
神经病学 | 100383篇 |
特种医学 | 51223篇 |
外国民族医学 | 660篇 |
外科学 | 196656篇 |
综合类 | 27073篇 |
现状与发展 | 1篇 |
一般理论 | 377篇 |
预防医学 | 95667篇 |
眼科学 | 27914篇 |
药学 | 94798篇 |
2篇 | |
中国医学 | 2427篇 |
肿瘤学 | 70600篇 |
出版年
2018年 | 13171篇 |
2017年 | 10008篇 |
2016年 | 10975篇 |
2015年 | 12456篇 |
2014年 | 17261篇 |
2013年 | 26371篇 |
2012年 | 36080篇 |
2011年 | 38100篇 |
2010年 | 22908篇 |
2009年 | 21856篇 |
2008年 | 36669篇 |
2007年 | 39255篇 |
2006年 | 39540篇 |
2005年 | 38473篇 |
2004年 | 37604篇 |
2003年 | 36458篇 |
2002年 | 35811篇 |
2001年 | 64011篇 |
2000年 | 66512篇 |
1999年 | 56441篇 |
1998年 | 15142篇 |
1997年 | 13770篇 |
1996年 | 14214篇 |
1995年 | 13453篇 |
1994年 | 12782篇 |
1993年 | 11799篇 |
1992年 | 44558篇 |
1991年 | 43466篇 |
1990年 | 42218篇 |
1989年 | 40114篇 |
1988年 | 36895篇 |
1987年 | 36237篇 |
1986年 | 33618篇 |
1985年 | 32280篇 |
1984年 | 24140篇 |
1983年 | 20270篇 |
1982年 | 11725篇 |
1981年 | 10693篇 |
1980年 | 9517篇 |
1979年 | 21343篇 |
1978年 | 14821篇 |
1977年 | 12533篇 |
1976年 | 11694篇 |
1975年 | 12625篇 |
1974年 | 14662篇 |
1973年 | 14120篇 |
1972年 | 12945篇 |
1971年 | 11731篇 |
1970年 | 11051篇 |
1969年 | 10025篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Molnár B. Aroca S. Dobos A. Orbán K. Szabó J. Windisch P. Stähli A. Sculean A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with... 相似文献
2.
3.
4.
5.
6.
7.
Raymond J. Chan RN PhD Vivienne E. Milch MBBS MHPol Fiona Crawford-Williams PhD Oluwaseyifunmi Andi Agbejule BRadTherapy Ria Joseph MNutrDiet Jolyn Johal BND Narayanee Dick BSc Matthew P. Wallen PhD Julie Ratcliffe PhD Anupriya Agarwal MBBS Larissa Nekhlyudov MD Matthew Tieu PhD Manaf Al-Momani BPharm Scott Turnbull PhD Rahul Sathiaraj MPH Dorothy Keefe MBBS MD Nicolas H. Hart PhD 《CA: a cancer journal for clinicians》2023,73(6):565-589
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs. 相似文献
8.
A Coupled FEM-BEM Approach for the Solution of the Free-Boundary Axi-Symmetric Plasma Equilibrium Problem
下载免费PDF全文
![点击此处可从《Communications In Computational Physics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
M. Bonotto D. Abate P. Bettini & F. Villone 《Communications In Computational Physics》2022,31(1):27-59
In this paper we present a coupled Finite Element Method – Boundary Element Method (FEM-BEM) approach for the solution of the free-boundary axi-symmetric
plasma equilibrium problem. The proposed method, obtained from an improvement
of the Hagenow-Lackner coupling method, allows to efficiently model the equilibrium
problem in unbounded domains by discretizing only the plasma region; the external
conductors can be modelled either as 2D or 3D models, according to the problem of interest. The paper explores different iterative methods for the solution of the nonlinear
Grad-Shafranov equation, such as Picard, Newton-Raphson and Newton-Krylov, in order to provide a robust and reliable tool, able to handle large-scale problems (e.g. high
resolution equilibria). This method has been implemented in the FRIDA code (FRee-boundary Integro-Differential Axisimmetric – https://github.
om/matteobonotto/
FRIDA), together with a suitable Adaptive Integration Technique (AIT) for the computation of the source term. FRIDA has been successfully tested and validated against
experimental data from RFX-mod device, and numerical equilibria of an ITER-like device. 相似文献
9.
Clinical & Experimental Metastasis - 相似文献
10.
目的 运用网络药理学方法及分子对接技术探讨黄芪干预腹膜纤维化的可能机制。方法 利用中药系统药理学数据库及分析平台(TCMSP)检索黄芪的主要化学成分及靶点,并补充文献报道相关药理作用的成分作为潜在活性成分。以"peritoneal fibrosis"为关键词分别在OMIM、Genecards获取目前已知的与腹膜纤维化相关的疾病靶点,后取两者的交集靶点;对交集基因通过STRING数据库与Cytoscape 3.7.2软件构建"药物-成分-靶点-疾病"网络及蛋白互作(PPI)网络并筛选核心网络。基于R软件使用Bioconductor生物信息软件对核心靶点进行GO及KEGG富集分析,最终采用AutoDock软件将主要有效成分与核心靶点进行分子对接,得出其结合能力。结果 筛选出20个黄芪活性成分及文献报道有相关药理作用4个, 457药物作用靶点,与674个腹膜纤维化病靶点取交集,得到86个共同靶点。GO功能富集分析提示黄芪拮抗腹膜纤维化主要参与了蛋白激酶B信号转导的调节、细胞对化学的应激反应、炎症反应的调节等通路; KEGG通路富集分析主要涉及调控肿瘤、磷脂酰肌醇-3-羟激酶-蛋白激酶B(PI3K-Akt)、晚期糖基化终末产物/晚期糖基化终末产物受体(AGE-RAGE)、人类巨细胞病毒感染、HIF-1信号通路等;分子对接结果显示关键靶点与活性成分具有较好的结合能力。结论 黄芪治疗腹膜纤维化的分子机制,可能与抑制炎症及氧化应激反应、调节多种信号通路等相关。 相似文献